Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis
- PMID: 31077075
- DOI: 10.1007/s12350-019-01736-6
Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) has a significant role in the development of coronary atherosclerosis, independent of traditional cardiovascular and metabolic risk factors. However, the role of myocardial glucose uptake in NAFLD patients who develop coronary atherosclerosis was unclear. The aim of the present study thus was to investigate the association between NAFLD with characteristic of coronary atherosclerotic plaque and myocardial glucose uptake measured by using 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET).
Methods and results: A total of 418 consecutive subjects who had undergone FDG PET/computed tomography (CT) and coronary computed tomography angiography (CCTA) were retrospectively investigated. Fatty liver was assessed by unenhanced CT. Coronary atherosclerotic plaques and stenosis on CCTA were evaluated. The metabolic parameters were measured on PET images. The ratio of the maximum myocardium FDG value to the mean standardized uptake value of liver (SUVratio) was calculated to estimate myocardial glucose uptake. The association of myocardial glucose uptake with NAFLD and coronary atherosclerosis was determined by multivariate logistic regression analysis. The proportion of low SUVratio in patients with NAFLD was significantly higher compared to those without NAFLD (45.00% vs 19.82%, P < .001). There was a significantly negative correlation between myocardial FDG uptake and hepatic steatosis in association trend analysis (P < .001). When the proportion of individuals with non-calcified plaque on CCTA is stratified by quartiles of SUVratio, patients with low quartiles of SUVratio were more likely to have higher proportion of non-calcified plaque than those with high quartiles of SUVratio (Q1 and Q2 vs Q3 and Q4, P = .003). The trend analysis presented correlated inversely relationship between non-calcified plaque and myocardial SUVratio (P = .001). Moreover, multivariate regression analysis showed that the low SUVratio was independently associated with NAFLD, non-calcified plaque, and significant stenosis after adjusting for clinically important factors.
Conclusion: We demonstrated that the presence of reduced myocardial glucose uptake in patients with NAFLD was independently associated with non-calcified plaque and significant stenosis, suggesting an increased risk of coronary atherosclerosis and future cardiovascular events.
Keywords: Non-alcoholic fatty liver disease; atherosclerosis; coronary computed tomography angiography; myocardial glucose uptake; positron emission tomography.
Comment in
-
Non-alcoholic fatty liver disease and coronary atherosclerosis-does myocardial glucose metabolism provide the missing link?J Nucl Cardiol. 2021 Apr;28(2):621-623. doi: 10.1007/s12350-019-01783-z. Epub 2019 Jun 14. J Nucl Cardiol. 2021. PMID: 31201689 No abstract available.
Similar articles
-
Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by 18F-FDG PET/CT.BMC Endocr Disord. 2020 May 27;20(1):75. doi: 10.1186/s12902-020-00556-x. BMC Endocr Disord. 2020. PMID: 32460891 Free PMC article.
-
Association between non-alcoholic fatty liver disease and myocardial glucose uptake measured by 18F-fluorodeoxyglucose positron emission tomography.J Nucl Cardiol. 2020 Oct;27(5):1679-1688. doi: 10.1007/s12350-018-1446-x. Epub 2018 Sep 20. J Nucl Cardiol. 2020. PMID: 30238301
-
Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.J Hepatol. 2018 May;68(5):1018-1024. doi: 10.1016/j.jhep.2017.12.012. Epub 2017 Dec 20. J Hepatol. 2018. PMID: 29274406
-
FDG PET/CT of the non-malignant liver in an increasingly obese world population.Clin Physiol Funct Imaging. 2020 Sep;40(5):304-319. doi: 10.1111/cpf.12651. Epub 2020 Jul 15. Clin Physiol Funct Imaging. 2020. PMID: 32529712 Review.
-
Non-FDG imaging of atherosclerosis: will imaging of MMPs assess plaque vulnerability?J Nucl Cardiol. 2012 Jun;19(3):609-17. doi: 10.1007/s12350-012-9553-6. J Nucl Cardiol. 2012. PMID: 22477642 Review.
Cited by
-
Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance.Cardiovasc Diabetol. 2023 Jan 9;22(1):4. doi: 10.1186/s12933-022-01733-z. Cardiovasc Diabetol. 2023. PMID: 36624469 Free PMC article.
-
Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic 18F-FDG-PET Study.Front Cardiovasc Med. 2022 Jun 29;9:924787. doi: 10.3389/fcvm.2022.924787. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35845046 Free PMC article.
-
Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis.Front Cardiovasc Med. 2022 Jan 10;8:824481. doi: 10.3389/fcvm.2021.824481. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35083304 Free PMC article. Review.
-
Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by 18F-FDG PET/CT.BMC Endocr Disord. 2020 May 27;20(1):75. doi: 10.1186/s12902-020-00556-x. BMC Endocr Disord. 2020. PMID: 32460891 Free PMC article.
References
-
- Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73-84. - DOI
-
- Lee SB, Park G-M, Lee J-Y, Lee BU, Park JH, Kim BG, et al. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study. J Hepatol 2018;68:1018-24. - DOI
-
- Lee HJ, Lee CH, Kim S, Hwang SY, Hong HC, Choi HY, et al. Association between vascular inflammation and non-alcoholic fatty liver disease: Analysis by (18)F-fluorodeoxyglucose positron emission tomography. Metabolism 2017;67:72-9. - DOI
-
- Sert A, Aypar E, Pirgon O, Yilmaz H, Odabas D, Tolu I. Left ventricular function by echocardiography, tissue doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease. Am J Cardiol 2013;112:436-43. - DOI
-
- Lee YH, Kim KJ, Yoo ME, Kim G, Yoon HJ, Jo K, et al. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients. J Hepatol 2018;68:764-72. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
